Trade

Poly Medicure share price

Balanced risk
  • 41%Low risk
  • 41%Moderate risk
  • 41%Balanced risk
  • 41%High risk
  • 41%Extreme risk
  • 2,106.20(-1.37%)
    July 18, 2025 15:29:53 PM IST
    • NSE
    • BSE
  • Vol : 129.94K (NSE + BSE)
    Last 20 day avg : 167.34 K

Poly Medicure is trading -1.37% lower at Rs 2,106.20 as compared to its last closing price. Poly Medicure has been trading in the price range of 2,135.55 & 2,097.40. Poly Medicure has given -18.37% in this year & -3.82% in the last 5 days. Poly Medicure has TTM P/E ratio 65.16 as compared to the sector P/E of 40.34.There are 4 analysts who have initiated coverage on Poly Medicure. There are - analysts who have given it a strong buy rating & - analysts have given it a buy rating. - analysts have given the stock a sell rating.The company posted a net profit of 91.83 Crores in its last quarter.Listed peers of Poly Medicure include Poly Medicure (-1.37%), Mallcom (india) (-2.84%), Prevest Denpro (-3.35%).The Mutual Fund holding in Poly Medicure was at 7.16% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Poly Medicure was at 11.44% in 31 Mar 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Jul 19, 2025, 08:28 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.16
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    8.21
    In line with historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    65.08
    Lower than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.39
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.07
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
2,097.40
Highest
2,135.55
52 week range
Lowest
1,788.05
Highest
3,350.00
Poly Medicure Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in March quarter by 16.60% from Rs 440.83 crore to Rs 378.07 crore, year-on-year
    • financial-insightsThe company has grown its March quarter profit by 34.34% from Rs 68.36 crore to Rs 91.83 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Poly Medicure Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 2,324.57
  • R2
  • 2,430.63
  • R3
  • 2,542.92
Pivot2,212.28
  • S1
  • 2,106.22
  • S2
  • 1,993.93
  • S3
  • 1,887.87
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Poly Medicure Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Poly Medicure
Bearish
2,106.20-1.3721,309.2965.718.210.130.03
Mallcom (india)
Moderately Bullish
1,267.20-2.84790.7320.672.610.240.84
Prevest Denpro
Bullish
575.00-3.35690.3536.996.360.18-
Nureca
Moderately Bearish
259.750.97259.75348.371.48-1.33
One Global Service Provider
Neutral
255.000.29180.6426.726.790.400.47
Poly Medicure Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Poly Medicure is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 62.44%
    • InsightsPromoter(s) have decreased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.87 percentage points from previous quarter
    • InsightsMutual Funds holding has decreased by 0.01 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    SBI Healthcare Opportunities Fund Regular Growth
    NA
    • Amount Invested (Cr.) 114.42
    • % of AUM 3.10
    Quant Small Cap Fund Growth
    4/5
    • Amount Invested (Cr.) 722.49
    • % of AUM 2.56
    Invesco India ESG Integration Stategy Fund Regular Growth
    3/5
    • Amount Invested (Cr.) 8.76
    • % of AUM 1.81
    Invesco India ELSS Tax Saver Fund Growth
    3/5
    • Amount Invested (Cr.) 50.68
    • % of AUM 1.78
    Tata Nifty MidSmall Healthcare Index Fund Regular Growth
    NA
    • Amount Invested (Cr.) 2.12
    • % of AUM 1.55
    Poly Medicure Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-06Audited Results & Final Dividend
    2025-02-03Quarterly Results & Others
    2024-10-28Quarterly Results & ESOP
    2024-07-22Quarterly Results
    2024-06-29Others
    About the company Poly Medicure
    • IndustryMedical Equipment & Supplies
    • ISININE205C01021
    • BSE Code531768
    • NSE CodePOLYMED
    Poly Medicure Limited is an India-based medical devices company. The Company is engaged in manufacturing and selling medical devices. The Company holds a portfolio of over 375 patents covering a range of products in various areas, including vascular access, renal care, transfusion and diagnostics systems. These products cater to a range of therapeutic segments, such as infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It supplies its products to more than 100 countries across Europe, Africa, the Americas, Australia, and Asia. Its products include IV cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others. It operates ten manufacturing facilities across India, China, Egypt and Italy.
    • Management Info
    • Naresh VijayvargiyaChief Financial Officer
    • Avinash ChandraCompliance Officer, Company Secretary
    • Himanshu BaidManaging Director, Executive Director
    • Rishi BaidJoint Managing Director, Executive Director
    • Vishal BaidExecutive Director
    • Ravi PrakashDeputy Company Secretary
    Poly Medicure Share Price FAQs

    Poly Medicure is trading at 2106.20 as on Fri Jul 18 2025 09:59:53. This is -1.37% lower as compared to its previous closing price of 2135.55.

    The market capitalization of Poly Medicure is 21309.29 Cr as on Fri Jul 18 2025 09:59:53.

    The 52 wk high for Poly Medicure is 3350.00 whereas the 52 wk low is 1788.05

    Poly Medicure can be analyzed on the following key metrics -

    • TTM P/E: 65.16
    • Sector P/E: 40.34
    • Dividend Yield: 0.16%
    • D/E ratio: 0.07

    Poly Medicure reported a net profit of 338.56 Cr in 2025.

    The Mutual Fund Shareholding was 7.16% at the end of 31 Mar 2025.